How UBS AM dealt with Covid-19 crunch

Buy-side risk survey: Swiss giant had planned for liquidity squeeze, says CRO – but not one like March

pandemic planning

This is the eighth in a series of articles connected to our buy-side risk survey. Click here to read the rest of the series.

Nasreen Kasenally started preparing her firm for a pandemic long before Covid-19 entered the global vocabulary.

When UBS Asset Management’s chief risk officer launched that work three years ago, she was not thinking about the spread of an incurable virus. Instead, she and her team had their eyes on a confluence of factors that would ultimately play a part in the stress

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: